The Poulopoulos Lab has been selected as a 2025 GenScript Life Science Research Grant recipient! This award will support our Crisaptics platform using Cas9-RC to develop genome therapeutics against neurological and neurodegenerative disease.
We’re grateful to GenScript for their commitment to advancing life science research and for supporting our work on genome therapeutics.
Learn more about the Life Science Research Grant program and the other awardees at https://www.genscript.com/grantprogram-2025.html